186 THIRD WHO REPORT ON NEGLECTED TROPICAL DISEASES *** Annex 2. Roadmap targets for eradicating and eliminating neglected tropical diseases, at a glance* Disease 2015 2020 Eradication Global elimination Regional elimination Country elimination Eradication Global elimination Regional elimination Country elimination Rabies Latin America Latin America Blinding trachoma Endemic treponematoses (yaws) Leprosy Chagas disease Transmission through blood transfusion interrupted Intra-domiciliary transmission interrupted in the Region of the Americas Human African trypanosomiasis In 80% of foci Visceral leishmanisis Indian subcontinent Dracunculiasis Lymphatic filariasis Onchocerciasis Latin America Selectd countries in Africa Schistosomiasis Eastern Mediterranean Region, Caribbean, Indonesia and the Mekong River basin Region of the Americas and Western Pacifi c Region Selected countries in Africa *Adapted from Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Geneva: World Health Organization; 2012 (WHO/HTM/NTD/2012.1).
*** ANNEXES 187 Annex 3. Classification of countries by income status* Income status Countries Low-income Middle-income Lower-middle-income Upper-middle-income Countries with GNI per capita, calculated using the World Bank Atlas method, of US$ 1045 or less in 2013. This group includes: Afghanistan, Bangladesh, Benin, Burkina Faso, Burundi, Cambodia, Central African Republic, Chad, Comoros, Democratic People’s Republic of Korea, Democratic Republic of the Congo, Eritrea, Ethiopia, Gambia, Guinea, Guinea- Bissau, Haiti, Kenya, Kyrgyzstan, Liberia, Madagascar, Malawi, Mali, Mozambique, Myanmar, Nepal, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Tajikistan, Togo, Uganda, United Republic of Tanzania and Zimbabwe. Countries with GNI per capita, calculated using the World Bank Atlas method, of more than US$ 1045 but less than US$ 12 746. This group includes both lower-middle and upper-middle-income countries. See lower-middle-income and upper-middle-income for lists of countries. Countries with GNI per capita, calculated using the World Bank Atlas method, of more than US$ 1045 but less than US$ 4125. This group includes: Armenia, Bhutan, Bolivia (Plurinational State of), Cape Verde, Cameroon, Congo, Côte d’Ivoire, Djibouti, Egypt, El Salvador, Georgia, Ghana, Guatemala, Guyana, Honduras, India, Indonesia, Kiribati, Lao People’s Democratic Republic, Lesotho, Mauritania, Micronesia (Federated States of), Mongolia, Morocco, Nicaragua, Nigeria, Pakistan, Papua New Guinea, Paraguay, Philippines, Republic of Moldova, Samoa, Sao Tome and Principe, Senegal, Solomon Islands, Sri Lanka, Sudan, Swaziland, Syrian Arab Republic, Timor-Leste, Ukraine, Uzbekistan, Vanuatu, Viet Nam, Yemen and Zambia. Countries with GNI per capita, calculated using the World Bank Atlas method, of more than US$ 4125 but less than US$ 12 746. This group includes: Albania, Algeria, Angola, Argentina, Azerbaijan, Belarus, Belize, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, China, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, Fiji, Gabon, Grenada, Hungary, Iran (Islamic Republic of), Iraq, Jamaica, Jordan, Kazakhstan, Lebanon, Libya, Malaysia, Maldives, Marshall Islands, Mauritius, Mexico, Montenegro, Namibia, Palau, Panama, Peru, Romania, Saint Lucia, Saint Vincent and the Grenadines, Serbia, Seychelles, South Africa, Suriname, Thailand, The Former Yugoslav Republic of Macedonia, Tonga, Tunisia, Turkey, Turkmenistan, Tuvalu and Venezuela (Bolivarian Republic of). GNI, gross national income. * Source: World Bank country and lending groups (http://data.worldbank.org/about/country-and-lending-groups).
- Page 1:
INVESTING TO OVERCOME THE GLOBAL IM
- Page 4 and 5:
ii THIRD WHO REPORT ON NEGLECTED TR
- Page 6 and 7:
iv THIRD WHO REPORT ON NEGLECTED TR
- Page 8:
vi THIRD WHO REPORT ON NEGLECTED TR
- Page 11 and 12:
*** FOREWORD ix FOREWORD BY THE DIR
- Page 13 and 14:
*** EXECUTIVE SUMMARY xi EXECUTIVE
- Page 15 and 16:
*** EXECUTIVE SUMMARY xiii for the
- Page 17 and 18:
*** EXECUTIVE SUMMARY xv Neglected
- Page 19 and 20:
*** THE RESOLUTION AND THE ROADMAP
- Page 21 and 22:
*** THE RESOLUTION AND THE ROADMAP
- Page 23 and 24:
*** THE RESOLUTION AND THE ROADMAP
- Page 25 and 26:
*** THE RESOLUTION AND THE ROADMAP
- Page 27 and 28:
*** THE RESOLUTION AND THE ROADMAP
- Page 29 and 30:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 31 and 32:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 33 and 34:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 35 and 36:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 37 and 38:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 39 and 40:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 41 and 42:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 43 and 44:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 45 and 46:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 47 and 48:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 49 and 50:
● ● ● ● ● ● ● ● ●
- Page 51 and 52:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 53 and 54:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 55 and 56:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 57 and 58:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 59 and 60:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 61 and 62:
*** INVESTING TOWARDS UNIVERSAL COV
- Page 63 and 64:
*** KEY INTERVENTIONS: SITUATION RE
- Page 65 and 66:
*** KEY INTERVENTIONS: SITUATION RE
- Page 67 and 68:
*** KEY INTERVENTIONS: SITUATION RE
- Page 69 and 70:
*** KEY INTERVENTIONS: SITUATION RE
- Page 71 and 72:
*** KEY INTERVENTIONS: SITUATION RE
- Page 73 and 74:
*** KEY INTERVENTIONS: SITUATION RE
- Page 75 and 76:
*** KEY INTERVENTIONS: SITUATION RE
- Page 77 and 78:
*** KEY INTERVENTIONS: SITUATION RE
- Page 79 and 80:
*** KEY INTERVENTIONS: SITUATION RE
- Page 81 and 82:
*** KEY INTERVENTIONS: SITUATION RE
- Page 83 and 84:
*** KEY INTERVENTIONS: SITUATION RE
- Page 85 and 86:
*** KEY INTERVENTIONS: SITUATION RE
- Page 87 and 88:
*** THE DISEASES − CHAPTER 4 69 I
- Page 89 and 90:
*** THE DISEASES − CHAPTER 4 71 I
- Page 91 and 92:
*** THE DISEASES − CHAPTER 4 73 p
- Page 93 and 94:
*** THE DISEASES − CHAPTER 4 75 4
- Page 95 and 96:
*** THE DISEASES − CHAPTER 4 77 E
- Page 97 and 98:
*** THE DISEASES − CHAPTER 4 79 T
- Page 99 and 100:
*** THE DISEASES − CHAPTER 4 81 1
- Page 101 and 102:
*** THE DISEASES − CHAPTER 4 83 I
- Page 103 and 104:
*** THE DISEASES − CHAPTER 4 85 A
- Page 105 and 106:
*** THE DISEASES − CHAPTER 4 87 F
- Page 107 and 108:
*** THE DISEASES − CHAPTER 4 89 4
- Page 109 and 110:
*** THE DISEASES − CHAPTER 4 91 F
- Page 111 and 112:
*** THE DISEASES − CHAPTER 4 93 I
- Page 113 and 114:
*** THE DISEASES − CHAPTER 4 95 4
- Page 115 and 116:
*** THE DISEASES − CHAPTER 4 97 I
- Page 117 and 118:
*** THE DISEASES − CHAPTER 4 99 M
- Page 119 and 120:
*** THE DISEASES − CHAPTER 4 101
- Page 121 and 122:
*** THE DISEASES − CHAPTER 4 103
- Page 123 and 124:
*** THE DISEASES − CHAPTER 4 105
- Page 125 and 126:
*** THE DISEASES − CHAPTER 4 107
- Page 127 and 128:
*** THE DISEASES − CHAPTER 4 109
- Page 129 and 130:
*** THE DISEASES − CHAPTER 4 111
- Page 131 and 132:
*** THE DISEASES − CHAPTER 4 113
- Page 133 and 134:
*** THE DISEASES − CHAPTER 4 115
- Page 135 and 136:
*** THE DISEASES − CHAPTER 4 117
- Page 137 and 138:
*** THE DISEASES − CHAPTER 4 119
- Page 139 and 140:
*** THE DISEASES − CHAPTER 4 121
- Page 141 and 142:
*** THE DISEASES − CHAPTER 4 123
- Page 143 and 144:
*** THE DISEASES − CHAPTER 4 125
- Page 145 and 146:
*** THE DISEASES − CHAPTER 4 127
- Page 147 and 148:
*** THE DISEASES − CHAPTER 4 129
- Page 149 and 150:
*** THE DISEASES − CHAPTER 4 131
- Page 151 and 152:
*** THE DISEASES − CHAPTER 4 133
- Page 153 and 154: *** THE DISEASES − CHAPTER 4 135
- Page 155 and 156: *** THE DISEASES − CHAPTER 4 137
- Page 157 and 158: *** THE DISEASES − CHAPTER 4 139
- Page 159 and 160: *** THE DISEASES − CHAPTER 4 141
- Page 161 and 162: *** THE DISEASES − CHAPTER 4 143
- Page 163 and 164: *** THE DISEASES − CHAPTER 4 145
- Page 165 and 166: *** THE DISEASES − CHAPTER 4 147
- Page 167 and 168: *** THE DISEASES − CHAPTER 4 149
- Page 169 and 170: *** THE DISEASES − CHAPTER 4 151
- Page 171 and 172: *** THE DISEASES − CHAPTER 4 153
- Page 173 and 174: *** THE DISEASES − CHAPTER 4 155
- Page 175 and 176: *** THE DISEASES − CHAPTER 4 157
- Page 177 and 178: *** THE DISEASES − CHAPTER 4 159
- Page 179 and 180: *** THE DISEASES − CHAPTER 4 161
- Page 181 and 182: *** THE DISEASES − CHAPTER 4 163
- Page 183 and 184: *** THE DISEASES − CHAPTER 4 165
- Page 185 and 186: *** THE DISEASES − CHAPTER 4 167
- Page 187 and 188: *** THE DISEASES − CHAPTER 4 169
- Page 189 and 190: *** THE DISEASES − CHAPTER 4 171
- Page 191 and 192: *** THE DISEASES − CHAPTER 4 173
- Page 193 and 194: *** THE DISEASES − CHAPTER 4 175
- Page 195 and 196: *** THE DISEASES − CHAPTER 4 177
- Page 197 and 198: *** ANNEXES 179 ANNEXES
- Page 199 and 200: *** ANNEXES 181 Annex 1a (cont’d)
- Page 201 and 202: *** ANNEXES 183 WHA66.12 Recognizin
- Page 203: *** ANNEXES 185 WHA66.12 3. REQUEST
- Page 207 and 208: *** ANNEXES 189 Annex 5. Medicines
- Page 209: *** ANNEXES 191 WHO REGIONAL OFFICE